Debevoise Advises TPG in Its Acquisition of a Majority Interest in OneOncology

20 April 2023

Debevoise & Plimpton LLP is advising TPG (NASDAQ: TPG) in its acquisition, alongside AmeriSourceBergen Corporation (NYSE: ABC), of OneOncology, a network of leading oncology practices, from General Atlantic. TPG has agreed to acquire a majority interest in OneOncology, and AmerisourceBergen will acquire a minority interest in the company. For more information, please see the company’s press release.

TPG is a leading global alternative asset management firm, founded in San Francisco in 1992, with $135 billion of assets under management and investment and operational teams around the world.

The Debevoise team is led by M&A partners Paul Bird and Spencer Gilbert and includes partners Andrew Bab, associates Erik Andren, Margaret Howard, Matthew Jahnle, Chika Ojukwu and Dominique Trudelle and law clerks Andrew Lee and Erick Wong, finance partners Ryan Rafferty and Jeffrey Ross, counsel Katarina Molnarova, associates Faridat Arogundade and Matthew Sacco and law clerk Shefit Koboci, tax partners Michael Bolotin and Stephen Jordan, associates Samuel Krawiecz and Robert Nelson-Sullivan and law clerks Avi Leiner and Sophie Mirzaian, benefits partner Jonathan Lewis, counsel Kathleen Emberger and associate Julia Adams, capital markets partner Nicholas Pellicani and associate Michael Stephan, intellectual property counsel Caroline Geiger, associates Katelyn Bryant and Paisley Piasecki, data strategy and security partner Erez Liebermann and associates Corey Goldstein and Jarrett Lewis, and antitrust partner Ted Hassi.